Therapeutic applications of oligonucleotides in medicine

Chemistry and Industry (London)

Volumn , Issue 3, 1996, Pages 90-93

  Crooke, Stanley T ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THERAPEUTIC APPLICATION;

OLIGONUCLEOTIDES;

EID: 1542429626     PISSN: 00093068     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (68)

1. Crooke, S.T., Therapeutic applications of oligonucleotides', Austin, Texas: R.G. Landes Co, 1995
2. Crooke, S.T., Ann. Review Pharmacol. Toxicol., 1992, 32, 329
3. Bennett, C.F., & Crooke, S.T., 'Regulation of endothelial cell adhesion molecule expression with antisense oligonucleotides', in 'Advances in pharmacology', (Eds J.T. August, M.W. Anders, F. Murad & J.T. Coyle), Volume 28, Academic Press, 1994, 1
4. Crooke, S.T., 'Oligonucleotide therapeutics', in 'Burger's medicinal chemistry and drug discovery', (Ed. M.E. Wolff) Volume 1, J. Wiley & Sons, 1995, 863
5. Stein, C.A., & Cheng, Y.C., Science, 1993, 261, 1004
6. Tso, P.O.P., Miller, P.S., & Greene, J.J., in 'Development of target oriented anticancer drugs', (Eds Y.C. Cheng, B. Goz & M. Minkoff), New York: Raven Press, 1983, 189; Zamecnik, P.C., & Stephenson, M.L., Proc. Natl Acad. Sci. USA, 1978, 75, 280
7. Tso, P.O.P., Miller, P.S., & Greene, J.J., in 'Development of target oriented anticancer drugs', (Eds Y.C. Cheng, B. Goz & M. Minkoff), New York: Raven Press, 1983, 189; Zamecnik, P.C., & Stephenson, M.L., Proc. Natl Acad. Sci. USA, 1978, 75, 280
8. Crooke, R.M., Anti-Cancer Drug Design, 1991, 6, 609
9. Crooke, R.M., 'In vitro and in vivo toxicology of first generation analogues', in 'Antisense research and applications', (Eds S.T. Crooke & B. Lebleu) Boca Raton: CRC Press, 1993, 427
10. Crooke, R.M., et al, submitted for publication
11. Neckers, L.M., 'Cellular internalization of oligodeoxynucleotides', in 'Antisense research and applications', (Eds S.T. Crooke & B. Lebleu) Boca Raton: CRC Press, 1993, 451
12. Cossum, P.A., et al, J. Pharmacol. & Exp. Therap., 1993, 267, 1181
13. Cossum, P.A., et al, ibid, 1994, 269, 89
14. Crooke, S.T., et al, ibid, 1994, 56, 641
15. Sands, H., et al, Mol Pharm., 1994, 45, 932
16. Agrawal, S., Temsamani J., & Tang, J.Y., Proc. Natl Acad. Sci., 1991, 88, 7595
17. Dean, N.M., & McKay, R., ibid, 1994, 91, 11762
18. Nishizuka, Y., Science, 1992, 258, 607
19. Dean, N.M., et al, submitted for publication
20. Hutcherson, S.L., et al, 'Antisense oligonucleotide safety and efficacy for CMV retinitis in AIDS patients', Abstract 35th int. conf. on antimicrobial agents & chemotherapy, 204
21. Simons, M., et al, Nature, 1992, 359, 67
22. Morishita R., et al, Proc. Natl Acad. Sci., 1993, 90, 8474
23. Abe, J., et al, Biochem. & Biophys. Res. Communic., 1994, 198, 16
24. Morishita R., Gibbons, G.H., Kaneda, Y., Ogihara, T., & Dzau, V.J., Gene, 1994, 149, 13
25. Simons, M., Edelman, E.R., & Rosenberg, R.D., J. Clin. Invest., 1994, 93, 2351
26. Gyurko, R., Wielbo, D., & Phillips, M.I., Regul. Pept., 1993, 49, 167
27. Phillips, M.I., Wielbo, D., & Gyurko, R., Kidney Int., 1994, 46, 1554
28. Suzuki, S., et al, Am. J. Physiol., 1994, 266, R1418
29. Burch, R.M., & Mahan, L.C., J. Clin. Invest., 1991, 88, 1190
30. Stepkowski, S.M., Tu, Y., Condon, T.P., & Bennett, C.F., J. Immunology, 1994, 10, 5336
31. Whitesell, L., Rosolen, A., & Neckers, L.M., Antisense Res. & Dev., 1991, 1, 343
32. Kitajima, I., et al, Science, 1992, 258, 1792
33. Ratajczak, M.Z., et al, Proc. Natl Acad. Sci., 1992, 89, 11823
34. Perlaky, L., et al., Anti-Cancer Drug Design, 1993, 8, 3
35. Higgins, K.A., et al, Proc. Natl Acad. Sci., 1993, 90, 9901
36. Dean, N.M., & McKay, R., ibid, 1994, 91, 11762
37. Hijiya, N., et al, ibid, 1994, 91, 4499
38. Schwab, G., et al, ibid, 1994, 91, 10460
39. Skorski, T., et al, ibid, 1994, 91, 4504
40. Chiasson, B.J., Hooper, M.L., Murphy, P.R., & Robertson, H.A., Eur. J. Pharmacol., 1992, 227, 451
41. Osen-Sand, A., et al, Nature, 1993, 364, 445
42. Amaratunga, A., Morin, P.J., Kosik, K.S., & Fine, R.E., J. Biol. Chem., 1993, 268, 17427
43. Flanagan, L.M., McCarthy, M.M., Brooks, P.J., Pfaff, D.W., & McEwen, B.S., Ann. NY Acad. Sci., 1993, 689, 520
44. Heilig, M., Engel, J.A., & Soderpalm. B., Eur. J. Pharmacol., 1993, 236, 339
45. Pollio, G., Xue, P., Zanisi, M., Nicolin, A., & Maggi, A., Mol. Brain Res., 1993, 19, 135
46. Zhang M., & Creese, I., Neurosci. Lett, 1993, 161:223, 4947
47. Wahlestedt, C., et al, Nature, 1993, 363, 260
48. Akabayashi, A., Wahlestedt, C., Alexander, J.T., & Leibowitz, S.F., Mol. Brain Res., 1994, 21, 55
49. Adams, J.U., et al, Regul. Pept., 1994, 54, 1
50. Castro-Alamancos, M.A., & Torres-Aleman, I., Proc. Natl Acad. Sci., 1994, 91, 10203
51. Adams, J.U., Chen, X.H., DeRiel, J.K, Adler, M.W., & Liu-Chen, L.-Y., Brain Res., 1994, 667, 129
52. Gillardon, F., et al, Eur. J. Neurosci., 1994, 6, 880
53. Hooper, M.L., Chiasson, B.J., & Robertson, H.A., Neuroscience, 1994, 63, 917
54. Woodburn, V.L., Hunter, J.C., Durieux, C. Post, J.A., & Hughes, J., Regul. Pept., 1994, 54, 327
55. Kindy, M.S., Neurosci. Res, Commun., 1994, 14, 175
56. Konradi, C., Cole, R.L., Heckers, S., & Hyman, S.E., J. Neurosci., 1994, 4, 5623
57. Lai, J., Bilsky, E.J., Rothman, R.B., & Porreca, F., Neuroreport, 1994, 5, 1049
58. Mani, S.K., et al, Endocrinoloy, 1994, 135
59. McCarthy, M.M., Masters, D.B., Rimvall, K., Schwartz-Gilbin, S., & Pfaff, D.W., Brain Res., 1994, 636, 209
60. Neuman, I., Porter, D.W.F., Landgraft, R., & Pittman, Q.J., Am. J. Phsiol., 1994, 267, R852
61. Ogo, H., et al, Gen. Pharmacol., 1994, 25, 1131
62. Skutella, T., Probst, J.C., Jirikowski, G.F., Holsboer, F., & Spanagel, R., Neurosci. Lett., 1994, 167, 55
63. Tischmeyer, W., Grimm, R., Schicknick, H., Brysch, W., & Schlingensiepen, K.-H., Neuroreport., 1994, 5, 1501
64. Zhang, S.-P., Zhou, L.-W., & Weiss, B., J. Pharmacol. Exp. Ther., 1994, 271, 1462
65. Zhou, L.-W., Zhang, S.-P., Qin, Z.-H., & Weiss, B., ibid, 1994, 268, 1015
66. Kulka, M., et al, Proc. Natl Acad. Sci., 1989, 86, 6868
67. Vlassov, V.V., 'Inhibition of tick-borne viral encephalitis expression using covalently linked oligonucleotide analogs', paper given at the meeting on 'Oligodeoxynucleotides as antisense inhibitors of gene expression, therapeutic implications', Rockville, MD, 18-21 June 1989
68. Offensperger, W.-B., The EMBO Journal, 1993, 12, 1257